Hu Mengyun, Yuan Lingling, Zhu Jie
School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Hospital of Chengdu University of Traditional Chinese Medicine, Oncology Department II, Chengdu, People's Republic of China.
J Inflamm Res. 2024 Sep 4;17:5985-6004. doi: 10.2147/JIR.S479794. eCollection 2024.
Colorectal cancer (CRC), as the third most common bisexual cancer worldwide, requires urgent research on its underlying mechanisms and intervention methods. NRF2 is an important transcription factor involved in the regulation of redox homeostasis, protein degradation, DNA repair, and other cancer processes, playing an important role in cancer. In recent years, the complex role of NRF2 in CRC has been continuously revealed: on the one hand, it exhibits a chemopreventive effect on cancer by protecting normal cells from oxidative stress, and on the other hand, it also exhibits a protective effect on malignant cells. Therefore, this article explores the dual role of NRF2 and its related signaling pathways in CRC, including their chemical protective properties and promoting effects in the occurrence, development, metastasis, and chemotherapy resistance of CRC. In addition, this article focuses on exploring the regulation of NRF2 in CRC ferroptosis, as well as NRF2 drug modulators (activators and inhibitors) targeting CRC, including natural products, compounds, and traditional Chinese medicine formulations.
结直肠癌(CRC)作为全球第三大常见的两性癌,迫切需要对其潜在机制和干预方法进行研究。NRF2是一种重要的转录因子,参与氧化还原稳态、蛋白质降解、DNA修复及其他癌症相关过程的调控,在癌症中发挥重要作用。近年来,NRF2在结直肠癌中的复杂作用不断被揭示:一方面,它通过保护正常细胞免受氧化应激对癌症具有化学预防作用;另一方面,它对恶性细胞也具有保护作用。因此,本文探讨NRF2及其相关信号通路在结直肠癌中的双重作用,包括它们在结直肠癌发生、发展、转移和化疗耐药中的化学保护特性及促进作用。此外,本文重点探讨NRF2在结直肠癌铁死亡中的调控作用,以及针对结直肠癌的NRF2药物调节剂(激活剂和抑制剂),包括天然产物、化合物和中药制剂。